Hayag, Aelon Luke N.

HRN: 22-13-83  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/21/2023
CEFUROXIME 1.5GM (VIAL)
09/21/2023
09/28/2023
IVT
290mg
Q8
PCAP-C; R/O PTB
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: